Example: Heart Attack

Clinical Trials on Congenital Generalized Lipodystrophy

Total 11 results

    • NCT04026178
      Recruiting
      Immunogenicity of Metreleptin in Patients With Generalized Lipodystrophy
      Conditions: Generalized Lipodystrophy
    • NCT04159415
      Active, not recruiting
      Study of REGN4461, a Leptin Receptor Agonist Antibody, in Patients With Generalized Lipodystrophy
      Conditions: Generalized Lipodystrophy
    • NCT04710056
      Available
      Expanded Access to REGN4461 for Patients With 1) Generalized Lipodystrophy, 2) Partial Lipodystrophy or 3) Monogenic Obesity Due to LEP or LEPR Loss of Function
      Conditions: Generalized Lipodystrophy; Partial Lipodystrophy; Monogenic Obesity Due to LEP or LEPR Loss of Function
    • NCT02262832
      Recruiting
      Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy
      Conditions: Lipodystrophy; Diabetes; Hyperlipidemia
    • NCT03553420
      Recruiting
      Registry for Patients With Lipodystrophy
      Conditions: Lipodystrophy Acquired; Lipodystrophy Congenital
    • NCT00896298
      Completed
      Trial of Leptin Replacement Therapy in Patients With Lipodystrophy
      Conditions: Hypoleptinemia; Generalized Lipodystrophy; Partial Lipodystrophy; Insulin Resistance
    • NCT04221152
      Recruiting
      A Extension Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance ( EMPIRE-02 )
      Conditions: Insulin Resistance - Type A; Insulin Resistance - Type B; Lipoatrophic Diabetes Mellitus; Insulin Resistance Syndrome
    • NCT04018365
      Recruiting
      A Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance
      Conditions: Insulin Resistance - Type A; Insulin Resistance - Type B; Lipoatrophic Diabetes Mellitus; Insulin Resistance Syndrome
    • NCT02577952
      Completed
      Lipodystrophy Connect Patient Registry
      Conditions: Lipodystrophy
    • NCT03514420
      Completed
      Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Partial Lipodystrophy (FPL)
      Conditions: Familial Partial Lipodystrophy
    • NCT00025883
      Completed
      Leptin to Treat Lipodystrophy
      Conditions: Lipodystrophy
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations